Immuno-Oncology – Asia Pacific – Clinical trial landscape

Immuno-Oncology (IO) has seen an explosion in development over the past five years. The Asia Pacific region is the fastest growing area globally in IO trials, with a CAGR nearing 20% between 2017 and 2021, compared to the rest of the world.

Scrip, in partnership with Novotech, invites you to explore the clinical trials landscape for IO in the APAC region.. Download your free white paper now for a data-packed look at:

Immuno-Oncology and global IO trial trends

The IO APAC clinical trial landscape by location, indication, and drug category

APAC growth drivers for IO clinical trials

The key opinion leaders (KOLs) in APAC immuno-oncology

Whitepaper

Complete the form below to download the content.

* - marks a required field

Email Address

First Name

Last Name

Address

City

Country

State

Post Code

Phone

Answer the following questions about your organization below:

Company Name

How many people are employed by your organization?

What is your company's revenue?

In which industry do you work?

Job Title

Job Level

By clicking ‘Submit’ you agree to our Terms of Use. We take your privacy seriously. For more information please read our Privacy Policy.